You just read:

Orexigen Therapeutics Announces Spanish Launch of Mysimba® (naltrexone HCl / bupropion HCl prolonged release) in Partnership with Laboratorios Farmacéuticos Rovi, S.A.

News provided by

Orexigen Therapeutics, Inc.

Jan 25, 2017, 07:40 ET